Xiamen Amoytop Biotech Hits Day Low Amid Price Pressure at CNY 70.60

Xiamen Amoytop Biotech Co. experienced a notable decline today, with the stock dropping by 3.22% as it reached an intraday low of CNY 70.60. This performance contrasts with the broader market, as the China Shanghai Composite index fell by only 1.26% during the same period. Over the past week, Xiamen Amoytop has seen a more significant downturn, with a decrease of 7.38%. In the last month, the stock has declined by 2.53%, while its year-to-date performance shows a drop of 15.28%. Despite these short-term challenges, the company has reported positive results for the last 18 consecutive quarters, showcasing a robust operational foundation. Financial metrics indicate that Xiamen Amoytop holds a market capitalization of CNY 29,448 million and a return on equity of 34.50%. The company has also achieved record net sales of CNY 1,216.02 million and an operating profit of CNY 472.2 million. However, it has underperformed the market over the past year, generating negative returns of 9.14% compared to the China Shanghai Composite's impressive 22.49% return.